Keywords: posts, healthy, increase, sales, earnings, 3rd-qtr, johnson
J&J posts healthy increase in sales and earnings for 3rd-qtr 2001
Article | 17 October 2001
Johnson & Johnson has reported net earnings up 15.6% at $1.53 billionfor the third quarter of 2001, while earnings per share improved 14% to $0.49. The ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
